INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTHRAX

File: 123096_sep96_decls12_0010.txt
Page: 0010
Total Pages: 32

Subject: INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTHRAX             

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003201

Folder Title: CAUTIONARY NOTE                                                                                 

Document Number:          2

Folder Seq  #:         14









             that         tious            of samples is ac=cpli@ wi@ the ACR atid to
                                                  and          is
             is            to @te                 of @es.              ted            for out of
             theater sauple             Is h3.ghly                 Sanpler. are          le, amd
                   y conf@ticn of BW attack is critical.

                   g. Rmdts of bi          cal and eryv             sample arelysis should be
             passed          tely to the

             3.2 Failure of the Bw                       on and sanplim              n* f@
                      will be the sick St4.

                   a- @ mwical              wM be vig@ for                   of large           of
             sm       it2M             of anthrax and        in= in the un3.tS or         Ug
             treatment far-3-lities. V@@im                              be V193.lant for sick
                     - @, @cal                           d deploy to siter.         fied with
             large           Of SM       l@              aTid/or botulmm              atid perform
             a rapid             test for           usim the          kit and assess
             botul.@           ties. Oonf                  and botulmm           ties as well as
             other medical threats will be             tely           to the @cal
             @ligenoe cbamel.

                   b- The S-21G-2 and S-31G-3 with ass              F    mmucal will p@h&
             the location of the units F               the BW pauents @ from.

                   c.         mits will be ratified            tely to begin
             antibiotic. At the @ tim these sm will cmplete their anthrax
             vaccimtlcn series. Vig             will be              for other anthrax positive
             cases.

                   d- If          patients       it dp_f@tive botul@                    selective
               ve care @ided.

                   e- See para loe- Bi          cal sanples fran patients will be immediately
             slipped to          iate ACR,           , ard/or OMM laboratories. Biamacal
             samples will be refrigerated and receive priority                . They @ be
             remived bY labOratOrY(ieS) Within 48 hMM aeter saloplim.                   @ for
                     of @les and                ticn of inf@ticn is @ided in ref@.
             Nate these laboratories are capable of processim biomedical samples, not
             eriv            sampler. unless

                   f - It is cr:Ltical that cha-in of           be              frua patient to
             the laboratories and within the laboratories. Sainples tire per            le, and
                   Y CMf@tlOn of BW attack is critical.








                                                         3-2

Document 32 f:/Week-36/BX003201/CAUTIONARY NOTE/interim medical doctrine bw defense against anth:12179609280113
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = CAUTIONARY NOTE
Folder Seq # = 14
Subject = INTERIM MEDICAL DOCTRINE BW DEFENSE AGAINST ANTH
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996